Skip to main content
. 2017 May 7;8(29):47389–47399. doi: 10.18632/oncotarget.17650

Figure 3. Expression of miR-493-5p in NSCLC and normal samples.

Figure 3

(A) miRNAs targeting to ITGB1 were predicted using three target genes online prediction programs (MIRDB, RNA22 and Targetscan). (B) Differential expression analysis of miR-124-3p and miR-493-5p in GSE61741 from GEO database including 71 lung cancer patients and 94 healthy individuals. (C) The levels of miR-493-5p in peripheral miRNA blood profiles (GSE24709) from 28 patients with lung cancerous and 19 normal controls were analyzed. (D) miR-493-5p expression levels in cancer vs. paired adjacent non-tumor tissue (n = 27). (E) miR-493-5p expression in tumor samples (n = 134) and adjacent non-tumor lung tissue (n = 27) were analyzed using qRT-PCR assay.